Grants and Contributions:
Title:
Market evaluation and business planning for antimicrobial peptide drugs.
Agreement Number:
941037
Agreement Value:
$44,225.00
Agreement Date:
Jan 6, 2020 - Oct 9, 2020
Description:
This project will support the firm to conduct market research and competitive intelligence studies and to develop a business plan and commercialization strategy for their antimicrobial peptide technology.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Vancouver, British Columbia, CA V6L 3C9
Reference Number:
172-2019-2020-Q4-941037
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
792352932
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 98 days. The total amended value is 15,000 dollars.
Amendment Date
Jun 17, 2020
Recipient's Legal Name:
Amphoraxe Life Sciences Inc.
Federal Riding Name:
Vancouver Quadra
Federal Riding Number:
59039
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
54171
Amendments: